by Clinical Neuropsychologist | Sunday, October 6, 2024 | Dementia
Abstract A brief history of events surrounding the conceptualization and original implementation of the Alzheimer’s Disease Neuroimaging Initiative (ADNI) as a public–private partnership (PPP) is provided from the perspective of three individuals directly...
by Clinical Neuropsychologist | Sunday, October 6, 2024 | Dementia
Abstract Diagnosing Alzheimer’s disease (AD) poses significant challenges to health care, often resulting in delayed or inadequate patient care. The clinical integration of blood-based biomarkers (BBMs) for AD holds promise in enabling early detection of...
by Clinical Neuropsychologist | Sunday, October 6, 2024 | Dementia
Abstract INTRODUCTION We evaluated the efficacy and safety of brexpiprazole for the treatment of agitation in Alzheimer’s dementia (AAD) in Japanese patients. METHODS This was a phase 2/3 multicenter, randomized, double-blind, placebo-controlled, parallel-group...
by Clinical Neuropsychologist | Sunday, October 6, 2024 | Dementia
Alzheimer’s &Dementia, EarlyView. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: Nilton Custodio, Ricardo Allegri, Francisco Lopera, Paulo...
by Clinical Neuropsychologist | Sunday, October 6, 2024 | Dementia
Abstract INTRODUCTION People with neurodegenerative disorders (ND) frequently face diagnostic delay and misdiagnosis. We investigated blood and cerebrospinal fluid (CSF) neurofilament light chain (NfL) to distinguish ND from primary psychiatric disorders (PPD), a...
